Ocugen Q2 R&D expenses surged driven by licensing cost for Covaxin in Canada
06 August 2021 - 10:09PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Apr 2024 to May 2024
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From May 2023 to May 2024